<?xml version="1.0" encoding="UTF-8"?>
<boxed-text id="BX1" position="float" orientation="portrait">
 <caption>
  <title>What this paper adds</title>
 </caption>
 <p>What is already known on this subject</p>
 <list list-type="bullet">
  <list-item>
   <p>The COVID-19 pandemic has presented one of the greatest challenges to healthcare worldwide.</p>
  </list-item>
  <list-item>
   <p>There has been an unprecedented global demand on supportive medicines, particularly in critical care.</p>
  </list-item>
  <list-item>
   <p>Given that this is a new virus, the existing evidence base to inform and predict critical care drug requirements is limited.</p>
  </list-item>
 </list>
 <sec>
  <title>What this study adds</title>
  <list list-type="bullet">
   <list-item>
    <p>The process developed is a collaborative and robust approach to assist in informing regional critical care drug requirements in response to the COVID-19 pandemic.</p>
   </list-item>
   <list-item>
    <p>The model is transferrable to other therapeutic classes and settings and can assist in informing medicine planning and preparedness in future epidemics/pandemics.</p>
   </list-item>
  </list>
 </sec>
</boxed-text>
